These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 4963585

  • 21. [The cholesterol ester composition in the serum in alcoholics and in Zieve's syndrome].
    Knüchel F.
    Med Welt; 1968 Feb 10; 6():367-70 passim. PubMed ID: 5713885
    [No Abstract] [Full Text] [Related]

  • 22. [Essential hyperlipemia and fibrinolysis].
    Blatny J, Kojecky Z, Fischerova E.
    Nouv Rev Fr Hematol; 1968 Feb 10; 8(2):259-61. PubMed ID: 4232374
    [No Abstract] [Full Text] [Related]

  • 23. [Hyperlipemia in flying personnel (civil aviation)].
    Anet P, Brouns H, van den Abelle KG, Delescluse A.
    Acta Cardiol; 1972 Feb 10; ():Suppl 15:75-85. PubMed ID: 4542790
    [No Abstract] [Full Text] [Related]

  • 24. Arterio-venous differences in the components of the fibrinolytic enzyme system.
    Ogston D, Ogston CM, Bennett NB.
    Thromb Diath Haemorrh; 1966 Jul 31; 16(1):32-7. PubMed ID: 4229628
    [No Abstract] [Full Text] [Related]

  • 25. [Studies on decrease of serum lipids and acceleration of fibrinolysis induced by phosphatidyl choline].
    Matsuo T, Yoshida M, Ishihama Y, Imamura H, Fukuzaki H.
    Naika Hokan; 1971 Sep 31; 18(9):355-60. PubMed ID: 5169518
    [No Abstract] [Full Text] [Related]

  • 26. Acute pancreatitis complicating idiopathic hyperlipemia.
    Gabryelewicz A, Kinalska I.
    Mater Med Pol; 1974 Sep 31; 6(3):220-2. PubMed ID: 4444338
    [No Abstract] [Full Text] [Related]

  • 27. [Research on experimental hyperlipemia. I. Hyperlipemia caused by bloodletting].
    Tayeau F, Nivet R, Dumas M, Jouzier E, Tixier M, Grouillé J.
    Bord Med; 1970 Sep 31; 3(9):1985-96. PubMed ID: 5481182
    [No Abstract] [Full Text] [Related]

  • 28. Impairment of the diurnal fibrinolytic response in man. Effects of aging, type IV hyperlipoproteinemia, and coronary artery disease.
    Rosing DR, Redwood DR, Brakman P, Astrup T, Epstein SE.
    Circ Res; 1973 Jun 31; 32(6):752-8. PubMed ID: 4715196
    [No Abstract] [Full Text] [Related]

  • 29. Atherothrombogenic risk modulation by n-3 fatty acids was not associated with changes in homocysteine in subjects with combined hyperlipidaemia.
    Grundt H, Nilsen DW, Hetland O, Mansoor MA, Aarsland T, Woie L.
    Thromb Haemost; 1999 Apr 31; 81(4):561-5. PubMed ID: 10235439
    [Abstract] [Full Text] [Related]

  • 30. Coagulation factors and components of the fibrinolytic system in lymph and blood in dogs.
    Leandoer L, Bergentz SE, Nilsson IM.
    Thromb Diath Haemorrh; 1968 Mar 31; 19(1):129-35. PubMed ID: 5652223
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
    Wada H, Mori Y, Okabayashi K, Gabazza EC, Kushiya F, Watanabe M, Nishikawa M, Shiku H, Nobori T.
    Am J Hematol; 2003 Jan 31; 72(1):1-7. PubMed ID: 12508260
    [Abstract] [Full Text] [Related]

  • 33. Effect of heparin and AMCA on coagulation and fibrinolysis in blood and lymph following massive haemorrhage in dogs.
    Leandoer L, Bergentz SE, Nilsson IM.
    Acta Chir Scand; 1969 Jan 31; 135(1):1-6. PubMed ID: 5805939
    [No Abstract] [Full Text] [Related]

  • 34. [Molecular mechanisms of fibrinolysis and perspectives of thrombolytic therapy].
    Veremeenko KN, Kizim AI.
    Vopr Med Khim; 1984 Jan 31; 30(5):13-22. PubMed ID: 6084892
    [Abstract] [Full Text] [Related]

  • 35. [Effect of angiotensin II on indices of the fibrinolysis system in experiments in vitro].
    Golubenkova NI.
    Lab Delo; 1981 Jan 31; (12):720-2. PubMed ID: 6172641
    [No Abstract] [Full Text] [Related]

  • 36. Fibrinolysis in human foetuses.
    Ekelund H, Hedner U, Astedt B.
    Acta Paediatr Scand; 1970 Jul 31; 59(4):369-76. PubMed ID: 4247258
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Changes in blood clotting factors after massive liver resection and total hepatectomy in dogs.
    Niléhn JE, Aronsen KF, Ericsson B.
    Acta Chir Scand; 1967 Jul 31; 133(3):183-8. PubMed ID: 6030165
    [No Abstract] [Full Text] [Related]

  • 39. Chemical control of hyperfibrinolytic states by synthetic inhibitors of fibrinolytic enzymes.
    Markwardt F, Klöcking HP.
    Biomed Biochim Acta; 1983 Jul 31; 42(6):725-30. PubMed ID: 6605748
    [Abstract] [Full Text] [Related]

  • 40. Effects of trans-4-aminomethylcyclohexane carboxylic acid as an antifibrinolytic agent on arterial wall and experimental atherosclerotic lesions in rabbits.
    Kato N, Morimatsu M, Tanaka K, Horie A.
    Thromb Diath Haemorrh; 1970 Oct 31; 24(1):85-99. PubMed ID: 5483976
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.